9960 — Kindstar Globalgene Technology Income Statement
0.000.00%
- HK$1.40bn
- HK$160.12m
- CNY927.57m
- 20
- 41
- 82
- 46
Annual income statement for Kindstar Globalgene Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 891 | 931 | 1,387 | 967 | 928 |
Cost of Revenue | |||||
Gross Profit | 459 | 484 | 599 | 450 | 440 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,851 | 2,383 | 1,301 | 916 | 973 |
Operating Profit | -960 | -1,452 | 85.8 | 51.4 | -45.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -962 | -1,454 | 83.3 | 43.3 | -56.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -970 | -1,454 | 77.5 | 36.4 | -60.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -974 | -1,454 | 75.5 | 41.3 | -54.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -974 | -1,454 | 75.5 | 41.3 | -54.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.07 | -2.92 | 0.125 | 0.022 | -0.058 |
Dividends per Share |